The emerging trend of inhaling 5MeO dimethyltryptamine in the nation presents significant hazards and complex statutory issues. Currently, 5MeO dimethyltryptamine remains a Controlled One substance under Canadian Controlled Drugs and Substances Act, making its possession and sale prohibited. While ingestion delivers the compound quickly, it also po